These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5004177)

  • 1. Immunohistological demonstration of insulin in islets of langerhans after stimulation of insulin secretion by glucose, sulphonylureas and insulin antibodies.
    Bürkle PA; Hemm G; Huber V; Federlin K
    Diabetologia; 1971 Dec; 7(6):423-30. PubMed ID: 5004177
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between glucose- and tolbutamide- induced insulin release and insulin content in single pancreatic rat islets.
    Steinke J; Patel TN; Ammon HP
    Metabolism; 1972 May; 21(5):465-70. PubMed ID: 4552618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
    Krause U; Puchinger H; Wacker A
    Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):455-60. PubMed ID: 5004179
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):449-54. PubMed ID: 5004178
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunohistological demonstration of insulin in pancreatic tissue.
    Federlin K; Bürkle PA; Hemm G
    Horm Metab Res; 1971; 3():Suppl 3:6-9. PubMed ID: 4949388
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of drugs on glucose and tolbutamide-stimulated insulin release from isolated rat islets of Langerhans.
    El-Denshary EE; Montague W
    Biochem Pharmacol; 1976 Jul; 25(13):1451-4. PubMed ID: 782457
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
    Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
    Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
    Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epinephrine and mannoheptulose on early and late phases of glucose-stimulated insulin release.
    Lernmark A; Hellman B
    Metabolism; 1970 Aug; 19(8):614-8. PubMed ID: 4913911
    [No Abstract]   [Full Text] [Related]  

  • 17. Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats.
    Hosokawa YA; Leahy JL
    Diabetes; 1997 May; 46(5):808-13. PubMed ID: 9133548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
    Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of glucose-induced insulin secretion in trypsin-treated islets of Langerhans.
    Krause U; Puchinger H; Wacker A
    Horm Metab Res; 1973 Sep; 5(5):325-9. PubMed ID: 4358422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolated islands of Langerhans. Methods of their isolation and study of insulin secretion].
    Sieradzki J; Wanat H; Grzymalska A
    Endokrynol Pol; 1980; 31(5):403-11. PubMed ID: 7011792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.